Ripamonti D - Search Results

1

Transplacental passage of ritonavir-boosted darunavir in two pregnant women.

Ripamonti D, Cattaneo D, Cortinovis M, Maggiolo F, Suter F. Ripamonti D, et al. Int J STD AIDS. 2009 Mar;20(3):215-6. doi: 10.1258/ijsa.2008.008515. Int J STD AIDS. 2009. PMID: 19255280 No abstract available.

2

Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer.

Ripamonti D, Cattaneo D, Maggiolo F, Airoldi M, Frigerio L, Bertuletti P, Ruggeri M, Suter F. Ripamonti D, et al. AIDS. 2007 Nov 30;21(18):2409-15. doi: 10.1097/QAD.0b013e32825a69d1. AIDS. 2007. PMID: 18025877 Clinical Trial.

3

Severe lactic acidosis and thiamine administration in an HIV-infected patient on HAART.

Arici C, Tebaldi A, Quinzan GP, Maggiolo F, Ripamonti D, Suter F. Arici C, et al. Among authors: ripamonti d. Int J STD AIDS. 2001 Jun;12(6):407-9. doi: 10.1258/0956462011923228. Int J STD AIDS. 2001. PMID: 11368826

4

Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution.

Arici C, Ripamonti D, Ravasio V, Maggiolo F, Rizzi M, Finazzi MG, Suter F. Arici C, et al. Among authors: ripamonti d. Int J STD AIDS. 2001 Sep;12(9):573-81. doi: 10.1258/0956462011923741. Int J STD AIDS. 2001. PMID: 11516366

5

Do lopinavir and ritonavir require a dose adjustment during pregnancy?

Ripamonti D, Cattaneo D. Ripamonti D, et al. J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):e64-5. doi: 10.1097/QAI.0000000000000155. J Acquir Immune Defic Syndr. 2014. PMID: 24694928 No abstract available.

6

Hepatitis C infection increases the risk of the modification of first highly active antiretroviral therapy in HIV-infected patients.

Ripamonti D, Arici C, Pezzotti P, Maggiolo F, Ravasio L, Suter F. Ripamonti D, et al. AIDS. 2004 Jan 23;18(2):334-7. doi: 10.1097/00002030-200401230-00028. AIDS. 2004. PMID: 15075556

7

HIV-1 and hepatitis B virus: time for a re-think?

Ripamonti D, Maggiolo F, Suter F. Ripamonti D, et al. Lancet. 2004 Apr 24;363(9418):1400. doi: 10.1016/S0140-6736(04)16067-4. Lancet. 2004. PMID: 15110510 No abstract available.

8

Switch strategies in patients on effective HAART.

Maggiolo F, Ripamonti D, Suter F. Maggiolo F, et al. Among authors: ripamonti d. J Antimicrob Chemother. 2005 Jun;55(6):821-3. doi: 10.1093/jac/dki119. Epub 2005 Apr 22. J Antimicrob Chemother. 2005. PMID: 15849261

9

Possible allergic cross-reaction to didanosine and tenofovir in an HIV-1-infected woman.

Ripamonti D, Maggiolo F, Suter F. Ripamonti D, et al. AIDS. 2007 May 11;21(8):1059-60. doi: 10.1097/QAD.0b013e3281053a42. AIDS. 2007. PMID: 17457107 No abstract available.

10

Prediction of Virologic Outcome of Salvage Antiretroviral Treatment by Different Systems for Interpreting Genotypic HIV Drug Resistance.

Maggiolo F, Airoldi M, Callegaro A, Ripamonti D, Gregis G, Quinzan G, Bombana E, Ravasio V, Suter F. Maggiolo F, et al. Among authors: ripamonti d. J Int Assoc Physicians AIDS Care (Chic). 2007 Jun;6(2):87-93. doi: 10.1177/1545109707299632. J Int Assoc Physicians AIDS Care (Chic). 2007. PMID: 17537998

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters